The immunological profile of RC17 hESC-derived dopaminergic neural progenitor cells in vitro: implications for the STEM-PD clinical trial. (2024)
Attributed to:
Immunogenicity test platform - in vitro and in vivo
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2024.01.23.576826
Publication URI: http://dx.doi.org/10.1101/2024.01.23.576826
Type: Preprint